跳至主要内容
临床试验/NCT06081985
NCT06081985已完成不适用

Efficacy of Deep Transcranial Magnetic Stimulation in Patients With Opioid Use Disorder

Pamukkale University2 个研究点 分布在 1 个国家目标入组 55 人开始时间: 2021年10月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
55
试验地点
2
主要终点
craving

研究概览

简要总结

Deep TMS to the left dorsolateral prefrontal cortex intervention to reduce craving and recurrent opioid use among patients with opioid use disorder who are abstinent for at least one week.

详细描述

The participants will undergo baseline assessments, including rating scales and urine opioid metabolite tests. The participants will receive one of two treatments: High-frequency (10Hz, 3000 pulses per session) dTMS using a double cone coil targeting the left dorsolateral prefrontal cortex or sham stimulation. Each treatment will be preceded by a short-guided imagery (2-3 min) design to activate the relevant brain circuitry (provocation of symptoms may increase the response rate to deep TMS as was evident in the treatment of PTSD, cigarette smoking, and OCD). dTMS sessions will be conducted 10 times per week for 2 weeks, for 20 sessions. 8 weeks of patient follow-up, including clinical visits at weeks 0, 2, and 8. During this phase, subjective and objective measures of opioid use (self-report and analysis of urine samples for opioid metabolite) will be collected. Following the completion of the main part by the individual, an "open-label" treatment using the same parameters of the experiment will be offered (regardless of the treatment group).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18- 65
  • Clinical diagnosis of opioid use disorder

排除标准

  • Currently pregnant or breastfeeding
  • Mental retardation, bipolar disorder, any psychotic disorder
  • Neurological diseases such as epilepsy, ischemic stroke, multiple sclerosis
  • History of head trauma that resulted in loss of consciousness for ≥5 minutes and retrograde amnesia for ≥30 minutes (self-reported history)
  • Any history of seizures other than febrile childhood seizures (self-reported history)
  • Clinically significant hearing impairment
  • Having any prosthesis, such as an implant and pacemaker.
  • Illiteracy

结局指标

主要结局

craving

时间窗: pretreatment, 2 weeks, and 8 weeks

craving severity for drug use- Visual Analog Scale (VAS). The minimum and maximum values are 0-10. Higher scores mean a worse outcome.

次要结局

  • Opioid use(8 weeks of treatment)
  • Impulsivity severity(pretreatment, 2 weeks, and 8 weeks)
  • Depression severity(pretreatment, 2 weeks, and 8 weeks)
  • Anxiety severity(pretreatment, 2 weeks, and 8 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Bengü Yücens

Medical Doctor, Associate Professor

Pamukkale University

研究点 (2)

Loading locations...

相似试验